D G Grahame-Smith

Misuse of temazepam.

D G Grahame-Smith, 1991, BMJ.

Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.

D G Grahame-Smith, S. Hjorth, T. Sharp, 1990, European journal of pharmacology.

Adenosine 3',5'-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex.

D G Grahame-Smith, R. Butcher, E. Sutherland, 1967, The Journal of biological chemistry.

5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis

D G Grahame-Smith, T. Sharp, T Sharp, 1989, British journal of pharmacology.

In Vivo Measurement of Extracellular 5‐Hydroxytryptamine in Hippocampus of the Anaesthetized Rat Using Microdialysis: Changes in Relation to 5‐Hydroxytryptaminergic Neuronal Activity

D G Grahame-Smith, T. Sharp, T Sharp, 1989, Journal of neurochemistry.